SelectQuote (SLQT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Sep, 2026Executive summary
Annual meeting scheduled for November 10, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by November 9, 2026.
Voting matters and shareholder proposals
Election of three Class I director nominees for a three-year term: Timothy R. Danker, Kavita K. Patel, and Christopher Wolfe.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending June 30, 2027.
Advisory vote to approve executive compensation for named executive officers.
Proposal to amend the Certificate of Incorporation to effect a reverse stock split (ratio between 1-for-10 and 1-for-20) and reduce authorized shares accordingly.
Proposal to approve adjournment of the meeting if additional proxies are needed for the reverse stock split.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director elections and corporate actions.
Latest events from SelectQuote
- Proxy covers director elections, auditor ratification, say-on-pay, and a reverse stock split proposal.SLQT
Proxy filing - Annual Meeting to vote on director elections, auditor ratification, executive pay, and a reverse stock split.SLQT
Proxy filing - Revenue and cash flow grew in 2026; 2027 targets higher margins and efficiency gains.SLQT
Q4 2026 - Diversified insurance and healthcare platform achieves strong growth and operational efficiency.SLQT
Investor presentation - Q3 FY2026 revenue up 6% to $430.9M, net income $40.2M, with robust segment growth and outlook.SLQT
Q3 2026 - Revenue up 12% to $537.1M, net income $69.3M, and guidance cut by $40M amid external headwinds.SLQT
Q2 2026 - FY2024 results surpassed expectations, with robust growth in revenue and profitability.SLQT
Q4 2024 - Revenue up 26% with strong pharmacy growth; $100M securitization boosts capital flexibility.SLQT
Q1 2025 - Q2 revenue up 19% to $481.1M, net income $53.2M, $350M equity investment secured.SLQT
Q2 2025